Federal Cannabis Decisions and State Initiatives

Federal Stance and Cannabis Rescheduling

The House Appropriations Committee’s recent decision to halt the rescheduling of marijuana highlights a significant moment in the ongoing conversation surrounding cannabis legislation. By also dismissing an amendment that would protect states’ recreational cannabis laws from federal intervention, this move emphasizes the tension between state rights and federal oversight.

The Price of Scientific Cannabis

In an unprecedented move, the National Institute of Standards and Technology has begun selling cannabis at $174 a gram, a price that outstrips what’s available commercially across the states. This development opens up a discourse on the accessibility and scientific scrutiny of cannabis, underscoring a shift towards more rigorous standards in cannabis research and consumption.

Advocacy for Equity in Cannabis Legalization

The Pennsylvania Legislative Black Caucus is pushing for a marijuana legalization framework that centers on equity and reparative justice. Their emphasis on providing relief for those adversely affected by past criminalization efforts reflects a broader desire within the cannabis community to address social injustices and ensure a fair industry.

Psychedelics on the Ballot

Washington State activists are making strides with a proposed ballot measure to legalize psychedelics derived from plants and fungi. This effort to introduce a regulated system for psychedelics not only highlights the growing acceptance of these substances for therapeutic use but also sets the stage for crucial discussions on future drug policies.